Correlation Between Metropolis Healthcare and Aarti Drugs

Can any of the company-specific risk be diversified away by investing in both Metropolis Healthcare and Aarti Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Metropolis Healthcare and Aarti Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Metropolis Healthcare Limited and Aarti Drugs Limited, you can compare the effects of market volatilities on Metropolis Healthcare and Aarti Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Metropolis Healthcare with a short position of Aarti Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Metropolis Healthcare and Aarti Drugs.

Diversification Opportunities for Metropolis Healthcare and Aarti Drugs

0.38

Correlation Coefficient

Metropolis Healthcare  Aarti Drugs

Weak diversification

The 3 months correlation between Metropolis and Aarti is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Metropolis Healthcare Limited and Aarti Drugs Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aarti Drugs Limited and Metropolis Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Metropolis Healthcare Limited are associated (or correlated) with Aarti Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aarti Drugs Limited has no effect on the direction of Metropolis Healthcare i.e., Metropolis Healthcare and Aarti Drugs go up and down completely randomly.

Pair Corralation between Metropolis Healthcare and Aarti Drugs

Assuming the 90 days trading horizon Metropolis Healthcare Limited is expected to generate 0.89 times more return on investment than Aarti Drugs. However, Metropolis Healthcare Limited is 1.12 times less risky than Aarti Drugs. It trades about 0.08 of its potential returns per unit of risk. Aarti Drugs Limited is currently generating about 0.01 per unit of risk. If you would invest  130,280  in Metropolis Healthcare Limited on September 19, 2024 and sell it today you would earn a total of  87,160  from holding Metropolis Healthcare Limited or generate 66.9% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Metropolis Healthcare Limited  vs.  Aarti Drugs Limited

Metropolis Healthcare

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Metropolis Healthcare Limited are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy essential indicators, Metropolis Healthcare is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Aarti Drugs Limited

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Aarti Drugs Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Metropolis Healthcare and Aarti Drugs

The main advantage of trading using opposite Metropolis Healthcare and Aarti Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Metropolis Healthcare position performs unexpectedly, Aarti Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aarti Drugs will offset losses from the drop in Aarti Drugs' long position.

The idea behind Metropolis Healthcare Limited and Aarti Drugs Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.